Neuro-Oncology Advances
metrics 2024
Empowering discoveries in the fight against brain tumors.
Introduction
Neuro-Oncology Advances, published by Oxford University Press, is an esteemed open-access journal dedicated to advancing the field of neuro-oncology. Established in 2019, the journal has quickly gained recognition for its commitment to disseminating high-quality research, evidenced by its impressive Q1 rankings in Neurology (Clinical), Oncology, and Surgery categories as of 2023. With a rigorous peer-review process and a focus on innovative findings, Neuro-Oncology Advances serves as a vital platform for researchers, practitioners, and students seeking to stay at the forefront of developments in the diagnosis and treatment of nervous system tumors. The journal is accessible globally, ensuring that critical knowledge is available to help improve clinical outcomes and foster collaboration within this crucial interdisciplinary field.
Metrics 2024
Metrics History
Rank 2024
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
Indian Journal of Neurosurgery
Shaping the Evolution of Neurosurgical Practices WorldwideIndian Journal of Neurosurgery, published by GEORG THIEME VERLAG KG, serves as a pivotal resource in the field of neurosurgery and clinical neurology. With an ISSN of 2277-954X and E-ISSN 2277-9167, this Open Access journal has made significant strides since its transition to an accessible format in 2012, ensuring that groundbreaking research is available to the global scientific community. The journal, situated in Stuttgart, Germany, aims to publish high-quality and innovative research, reviews, and discussions that address contemporary challenges in neurosurgery. Despite its recent ranking of 465/551 in Medicine (Surgery) and 361/400 in Medicine (Neurology - clinical), with percentiles of 15% and 9% respectively, the Indian Journal of Neurosurgery fosters a platform for emerging ideas that can propel advancements in neurosurgical practices. Researchers, professionals, and students are encouraged to contribute to and benefit from this dynamic publication, which continues to influence the evolution of neurosurgical knowledge and practices.
Clinical Lung Cancer
Empowering clinicians with cutting-edge lung cancer studies.Clinical Lung Cancer is a prestigious journal published by CIG MEDIA GROUP, LP, dedicated to advancing the field of oncology and pulmonary medicine since its establishment in 2000. With an impressive impact factor and high ranking within its fields—achieving Q1 status in Oncology and Pulmonary and Respiratory Medicine in 2023—this journal serves as a vital resource for researchers, clinicians, and students alike. Covering a wide scope of topics related to lung cancer, Clinical Lung Cancer offers a platform for innovative studies, clinical trials, and comprehensive reviews that contribute to both theory and practice. While it operates on a subscription basis, the quality of content is reflected in its ranked status within the top quartile of cancer research journals. This journal plays a critical role in shaping the future of lung cancer research and treatment, making it an essential destination for those looking to stay at the forefront of the field.
Brazilian Neurosurgery-Arquivos Brasileiros de Neurocirurgia
Transforming Research into PracticeBrazilian Neurosurgery-Arquivos Brasileiros de Neurocirurgia, published by GEORG THIEME VERLAG KG, is a distinguished peer-reviewed open access journal that has been making significant contributions to the field of neurosurgery since its transition to open access in 2015. This Brazilian journal, which is accessible to a global audience, aims to disseminate high-quality research articles, reviews, and case reports that enhance the understanding and practice of neurosurgery and clinical neurology. Despite its current ranking in the Q4 category for both neurology and surgery in 2023, the journal is committed to improving its impact and accessibility for researchers, medical professionals, and students worldwide. As an important platform for innovative ideas and discussions, it takes pride in publishing scientifically rigorous content that informs and shapes the future of neurosurgical practices. With the rise of open access publishing, Brazilian Neurosurgery aligns itself with contemporary trends, making vital research readily available to its diverse readership while nurturing academic collaborations within the neurosurgical community.
CLINICAL NEUROLOGY AND NEUROSURGERY
Advancing Neurological Insights for Tomorrow's CareCLINICAL NEUROLOGY AND NEUROSURGERY, published by Elsevier, is a pivotal journal in the fields of neurology and neurosurgery, recognized for its rigorous peer-review process and commitment to advancing clinical practices. Established in 1974, the journal has become a respected source of innovative research, evidenced by its excellent Scopus rankings—placing it within the top half of journals in both Medicine (Surgery) and the clinical aspect of Neurology. Notably, it has achieved a Q2 ranking in both Medicine (miscellaneous) and Surgery, and Q3 in Neurology (clinical) as of 2023. The journal publishes a wide array of articles focused on the latest findings, clinical practices, and technological advancements that address neurological disorders and surgical interventions. While it does not currently operate under an open-access model, it remains highly accessible to academic institutions and professionals worldwide from its editorial base in the Netherlands. By enabling knowledge-sharing and fostering collaboration among researchers, practitioners, and students, CLINICAL NEUROLOGY AND NEUROSURGERY plays a crucial role in shaping the future of clinical neurology and surgical techniques.
ACTA NEUROPATHOLOGICA
Advancing the Frontiers of NeuropathologyACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.
Molecular Oncology
Fostering Excellence in Molecular Oncology Studies.Molecular Oncology, published by WILEY, is a premier open-access journal that has been at the forefront of cancer research since its inception in 2007. With an impressive impact factor reflective of its outstanding contribution to the field, it holds a prestigious position in the Q1 category across multiple disciplines, including Cancer Research, Genetics, and Molecular Medicine. This journal is essential for researchers and professionals seeking to publish high-quality findings in a rapidly evolving area of study, underscored by its significant Scopus rankings that place it within the top percentiles of Oncology and Molecular Biology. As an open-access journal since 2017, it ensures that vital research is readily available to a global audience, thereby facilitating collaboration and knowledge dissemination among academic and clinical communities. With its commitment to innovative and impactful research, Molecular Oncology continues to be a critical resource for advancing our understanding of cancer biology and treatment.
NEURO-ONCOLOGY
Exploring Innovative Treatments in Neuro-OncologyNEURO-ONCOLOGY, a leading journal published by OXFORD UNIVERSIT PRESS INC, is at the forefront of research in the intersection of neurology and oncology, with contributions spanning from 1999 to 2024. With a recognized impact reflected in its strong ranking, holding Q1 status in Cancer Research, Neurology (Clinical), and Oncology categories, NEURO-ONCOLOGY provides a vital platform for the dissemination of groundbreaking studies and advancements in brain tumor research and treatment. The journal ranks impressively within the 99th percentile in clinical neurology and 96th percentile in oncology, highlighting its significance and influence within the field. Accessible through institutional subscriptions, it serves as a valuable resource for researchers, healthcare professionals, and students seeking to stay informed of the latest developments, therapeutic strategies, and scientific discussions in neuro-oncology.
Brain and Spine
Connecting minds: Bridging the gap between brain function and spinal health.Brain and Spine is a premier academic journal published by ELSEVIER, dedicated to advancing the fields of neuroscience and neurology. With its unique focus on the complex interactions between brain function and spinal health, this journal serves as an essential resource for researchers, clinicians, and students alike. Though currently lacking an official impact factor, its ranking within Scopus highlights its relevance, placing it in the 25th percentile for neuroscience (miscellaneous) and the 23rd percentile within neurology, indicating that while it is a developing journal, it holds potential for significant contributions to the field. Operating under open-access principles, it aims to disseminate valuable findings widely, ensuring that novel insights into neurological health are accessible to a global audience. Brain and Spine seeks to foster interdisciplinary collaboration and innovation, making it an invaluable platform for those striving to enhance our understanding of the brain and spinal cord's intricate functions and interdependencies.
ONCOLOGY
Elevating the standards of oncology research and practice.ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.
Journal of Cancer
Innovative insights for a cancer-free future.Journal of Cancer is a premier, peer-reviewed academic journal published by IVYSPRING INTERNATIONAL PUBLISHING that focuses on advancing the field of oncology. With an impact factor reflecting its significant contributions, this journal ranks in the 80th percentile of medical journals pertaining to oncology, positioning it at #79 out of 404 in Scopus. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that groundbreaking research reaches a global audience without barriers. Based in Australia, the journal addresses a wide array of topics within cancer research, catering to researchers, healthcare professionals, and students committed to enhancing their understanding of the complexities of cancer. Amidst evolving challenges in oncology, the Journal of Cancer serves as a vital platform for disseminating innovative findings, fostering collaboration, and promoting informed decisions that can lead to improved cancer outcomes worldwide.